1. Australian Government, Department of Health: Therapeutic Goods Administration (2019a). Direction about advertisements: Auzsupps Pty Ltd. https://www.tga.gov.au/direction-about-advertisements-auzsupps-pty-ltd; and Direction about advertisements: ESR You Pty Ltd. https://www.tga.gov.au/direction-about-advertisements-esr-you-pty-ltd
2. Australian Government, Department of Health: Therapeutic Goods Administration (2019b) Redback SARMs pays fine for advertising prescription-only. https://www.tga.gov.au/media-release/redback-sarms-pays-fine-advertising-prescription-only-substances
3. Basaria S, Collins L, Dillon EL, Orwoll K, Storer TW, Miciek R, Ulloor J, Zhang A, Eder R, Zientek H, Gordon G, Kazmi S, Sheffield-Moore M, Bhasin S (2013) The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men. J Gerontol Ser A Biol Sci Med Sci 68(1):87–95. https://doi.org/10.1093/gerona/gls078
4. Burmeister MA, Fincher TK, Graham WH (2020) Recreational use of selective androgen receptor modulators. US Pharm 45(60):15–18
5. Cox HD, Eichner D (2017) Detection of LGD-4033 and its metabolites in athlete urine samples. Drug Test Anal 9(1):127–134. https://doi.org/10.1002/dta.1986